Quoting Felipe Roitberg, Technical Officer (Cancer-NCD) at the World Health Organization, Ukraine, on LinkedIn:
“Just out our publication!
World Health Organization (WHO) Essential Medicines List applications and decisions reviewed in the context of ESMO-Magnitude of Clinical Benefit Scale (MCBS)- value-based scale.
A powerful tool for decision-making process support: pre-selection of cancer medicines.
Real cases to illustrate it
— Affordability is still a major barrier for adoption.”
For the article, click here.
Source: Felipe Roitberg/LinkedIn.